{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-031560","form_type":"8-K","ticker":"EXOZ","cik":"0002010788","company_name":"EXOZYMES INC.","filed_at":"2026-07-01T20:30:29+00:00","discovered_at":"2026-07-01T20:32:19.409355+00:00","generated_at":"2026-07-01T20:32:34.654121+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"eXoZymes closes $640K unit offering of 35,555 units at $18/unit","bullets":["Gross proceeds $639,990 from 35,555 units at $18/unit; net ~$565K after commissions and expenses.","Each unit: 2 shares of common stock + 1 warrant; share price $8.99, warrant $0.02.","Warrants exercisable at $11.24/share from June 5, 2027 to June 5, 2031; reset if shares sold below $8.99 before June 5, 2027.","Placement agent MDB Capital receives 7% fee and warrants for 10% of securities sold.","Net proceeds to be used for NCT business development, R&D, and working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-031560","json":"https://secwatch.observer/filing/0001493152-26-031560.json","markdown":"https://secwatch.observer/filing/0001493152-26-031560.md","text":"https://secwatch.observer/filing/0001493152-26-031560.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226031560/0001493152-26-031560-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226031560/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-01T20:32:34.654121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}